Literature DB >> 16584443

Streptococcus agalactiae sepsis after transfusion of a plateletpheresis concentrate: benefit of donor evaluation.

Wesley T Stevens1, Charles D Bolan, Jaime M Oblitas, David F Stroncek, John E Bennett, Susan F Leitman.   

Abstract

BACKGROUND: Bacterial contamination of platelet (PLT) components is an important cause of transfusion reactions. Recent efforts have focused on heightened surveillance to detect contamination before transfusion to limit recipient morbidity and mortality. Although identifying the cause of contamination is most often viewed in the context of recipient safety, this case illustrates the importance of a thorough evaluation on donor safety. CASE REPORT: A 68-year-old woman experienced a severe febrile reaction after a plateletpheresis transfusion. Blood cultures from the patient and from the plateletpheresis component were both positive for the presence of Streptococcus agalactiae. No abnormalities were identified on review of collection and processing records. The donor was asymptomatic and had a negative review of systems, a normal physical exam, normal laboratory values, and negative blood and urine cultures. One of three stool samples was positive for the presence of occult blood. Colonoscopy revealed a Dukes Stage B colonic adenocarcinoma. Fifteen months after surgical resection and adjuvant chemotherapy, the donor had no evidence of recurrent tumor.
CONCLUSION: Identification of bacteria in blood components should trigger a comprehensive donor evaluation, particularly if donor bacteremia is suspected. Organisms that may be associated with an enteric source should prompt a thorough gastrointestinal evaluation. Because the primary reservoir of S. agalactiae in the human body is the gastrointestinal tract, and because no findings suggested an alternate portal of entry in our male donor, a gastrointestinal source was suspected. In this case, an evaluation for organism-specific pathology led to early identification of a potentially curable large bowel lesion.

Entities:  

Mesh:

Year:  2006        PMID: 16584443     DOI: 10.1111/j.1537-2995.2006.00760.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Is there a need for bacterial endocarditis prophylaxis in patients undergoing gastrointestinal endoscopy?

Authors:  Salvatore Patanè
Journal:  J Cardiovasc Transl Res       Date:  2014-02-25       Impact factor: 4.132

2.  Is there a need for bacterial endocarditis prophylaxis in patients undergoing urological procedures?

Authors:  Salvatore Patanè
Journal:  J Cardiovasc Transl Res       Date:  2014-02-25       Impact factor: 4.132

3.  Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone.

Authors:  Karen Quillen; Phyllis Byrne; Yu Ying Yau; Susan F Leitman
Journal:  Transfusion       Date:  2009-03       Impact factor: 3.157

4.  Ricolinostat promotes the generation of megakaryocyte progenitors from human hematopoietic stem and progenitor cells.

Authors:  Jianan Jiang; Jinhua Qin; Jisheng Li; Xiaosong Lin; Bowen Zhang; Zeng Fan; Lijuan He; Quan Zeng; Wen Yue; Min Zheng; Xuetao Pei; Yanhua Li
Journal:  Stem Cell Res Ther       Date:  2022-02-05       Impact factor: 6.832

5.  Human endometrial stromal stem cells differentiate into megakaryocytes with the ability to produce functional platelets.

Authors:  Jinju Wang; Shuzhen Chen; Cheng Zhang; Samantha Stegeman; Teresa Pfaff-Amesse; Ying Zhang; Wenfeng Zhang; Lawrence Amesse; Yanfang Chen
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.